Cite
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma
MLA
Ruggiero, Antonio, et al. “Phase I Study of Temozolomide Combined with Oral Etoposide in Children with Recurrent or Progressive Medulloblastoma.” European Journal of Cancer, vol. 46, no. 16, Nov. 2010, pp. 2943–49. EBSCOhost, https://doi.org/10.1016/j.ejca.2010.05.016.
APA
Ruggiero, A., Rizzo, D., Attinà, G., Lazzareschi, I., Mastrangelo, S., Maurizi, P., Migliorati, R., Bertolini, P., Pastore, M., Colosimo, C., & Riccardi, R. (2010). Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. European Journal of Cancer, 46(16), 2943–2949. https://doi.org/10.1016/j.ejca.2010.05.016
Chicago
Ruggiero, Antonio, Daniela Rizzo, Giorgio Attinà, Ilaria Lazzareschi, Stefano Mastrangelo, Palma Maurizi, Roberta Migliorati, et al. 2010. “Phase I Study of Temozolomide Combined with Oral Etoposide in Children with Recurrent or Progressive Medulloblastoma.” European Journal of Cancer 46 (16): 2943–49. doi:10.1016/j.ejca.2010.05.016.